Lewis Gryziewicz
General Counsel chez ANAPTYSBIO, INC.
Profil
Lewis Gryziewicz is currently the Vice President-Regulatory Affairs at AnaptysBio, Inc. He previously held the same position at Macrocure Ltd.
in 2015.
Gryziewicz earned an MBA from Fairleigh Dickinson University in 1996, a doctorate from The University of Colorado in 2006, and an undergraduate degree from the University of the Sciences in Philadelphia in 1986.
Postes actifs de Lewis Gryziewicz
| Sociétés | Poste | Début |
|---|---|---|
| ANAPTYSBIO, INC. | General Counsel | 01/01/2019 |
Anciens postes connus de Lewis Gryziewicz
| Sociétés | Poste | Fin |
|---|---|---|
| MACROCURE LTD | General Counsel | 31/12/2015 |
Formation de Lewis Gryziewicz
| Fairleigh Dickinson University | Masters Business Admin |
| The University of Colorado | Doctorate Degree |
| University of the Sciences in Philadelphia | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ANAPTYSBIO, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Macrocure Ltd.
 Macrocure Ltd. Medical SpecialtiesHealth Technology Macrocure Ltd. is a clinical-stage biotechnology company, which engages in the development and commercialization of advanced cell therapy products. Its product, CureXcell, is an advanced wound care therapy that treat such wounds by injecting living human white blood cells that have been activate to facilitate the healing process. The company was founded by David Ben-Ami on January 14, 2008 and is headquartered in Petach Tikva, Israel. | Health Technology |
